FDA Announces Draft Guidance on Mixing, Diluting, or Repackaging Biological Products

Summary

The FDA is releasing a draft guidance outlining the circumstances under which it will not take enforcement action against pharmacies, facilities, or outsourcing companies that mix, dilute, or repack certain biological products without a license, as long as they follow specific conditions.